Cargando…

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?

The treatment of human immunodeficiency virus (HIV) has greatly advanced over the past few decades from complex regimens, with high toxicities, multiple daily dosing, and incomplete viral suppression to more simplified, highly effective, daily oral regimens. Although these advancements greatly impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brizzi, Marisa, Pérez, Sarah E., Michienzi, Sarah M., Badowski, Melissa E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893397/ https://www.ncbi.nlm.nih.gov/pubmed/36741193 http://dx.doi.org/10.1177/20499361221149773

Ejemplares similares

Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
por: Michienzi, Sarah M., et al.
Publicado: (2021)

1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS
por: Brizzi, Marisa B, et al.
Publicado: (2019)

Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
por: Brizzi, Marisa B, et al.
Publicado: (2020)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
por: Chastain, Daniel, et al.
Publicado: (2019)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
por: Murdock, Rachel M., et al.
Publicado: (2019)

1532. Guideline Adherence to Hepatitis B Virus (HBV) Screening and Vaccination in Patients Prescribed Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP)
por: Awad, Reham S, et al.
Publicado: (2023)

Long-acting injectable antiretrovirals for HIV treatment and prevention
por: Spreen, William R., et al.
Publicado: (2013)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

Can vitamins and/or supplements provide hope against coronavirus?
por: Michienzi, Sarah M, et al.
Publicado: (2020)

356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment
por: Michienzi, Sarah M, et al.
Publicado: (2019)

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
por: Kim, Yeon-Sook
Publicado: (2021)

939. Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
por: Poondi, Nivedha, et al.
Publicado: (2020)

Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study
por: Rutstein, Sarah E., et al.
Publicado: (2022)

Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1
por: Badowski, Melissa, et al.
Publicado: (2020)

Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users
por: Slama, Laurence, et al.
Publicado: (2023)

Vitamins, supplements and COVID-19: a review of currently available evidence
por: Speakman, Lauren L, et al.
Publicado: (2021)

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
por: Koester, Kimberly A., et al.
Publicado: (2023)

Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
por: Badowski, Melissa E, et al.
Publicado: (2016)

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
por: Benning, Lorie, et al.
Publicado: (2020)

941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
por: Michienzi, Sarah M, et al.
Publicado: (2020)

Telemedicine for HIV Care: Current Status and Future Prospects
por: Smith, Erica, et al.
Publicado: (2021)

Antiretroviral Stewardship: A Review of Published Outcomes with Recommendations for Program Implementation
por: Michienzi, Sarah M., et al.
Publicado: (2020)

1313. Complementary Effects of Medical Follow-up and Virologic Suppression for Reincarcerated Inmates Living with HIV
por: Badowski, Melissa E, et al.
Publicado: (2019)

1600. Long-Acting Antiretroviral Injectable: Who Would Benefit?
por: Pogorzelski, Karolina, et al.
Publicado: (2023)

2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy
por: Januszka, Jenna, et al.
Publicado: (2022)

Factors Associated with Preferences for Long-Acting Injectable Antiretroviral Therapy Among Adolescents and Young People Living with HIV in South Africa
por: Toska, Elona, et al.
Publicado: (2023)

Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2019)

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

2236. Direct-Acting Antivirals: Efficacy in a Real-World, Urban, Undeserved, HIV-HCV Co-Infected Population
por: Michienzi, Sarah, et al.
Publicado: (2018)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
por: Bunnell, Kristen L., et al.
Publicado: (2018)

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015)

Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability
por: Fletcher, Laura, et al.
Publicado: (2023)

Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use
por: Badowski, Melissa E, et al.
Publicado: (2019)

“A dream come true”: Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania
por: Kerrigan, Deanna, et al.
Publicado: (2020)

Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center
por: Koren, David E., et al.
Publicado: (2020)

Injectable Antiretroviral Drugs: Back to the Future
por: Berruti, Marco, et al.
Publicado: (2021)

The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment
por: Castor, Delivette, et al.
Publicado: (2020)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
por: Michienzi, Sarah M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6mq62kdns6jpks4d7hk83v9f6u